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The Idiopathic Respiratory Distress Syndrome of the newborn (RDS), 
accounts for twenty percent of all neonatal deaths and claims 12,000 
lives a yearJ Great advances have been made in understanding the 
pathogenesis of this disease, and new modalities of treatment and 
methods of prevention have emerged from this understanding. However, 
much remains to be done and many infants continue to succumb. 
2 
The pathologic hallmark of RDS is generalized atelectasis, and 
if the infant lives longer than a few hours after birth, the classi¬ 
cal hyaline membrane can be demonstrated. It is now believed that 
the hyaline membrane does not cause atelectasis but is a secondary 
finding resulting from tissue necrosis and the transudation of fibrin 
and other plasma proteins into terminal bronchioles and alveolar 
ducts. 
3 
In 1959 Avery and Mead discovered that lung wash material from 
infants that had succumbed to RDS lacked, or was deficient in, a 
surface active substance that was present in the lungs of infants 
that had died of non-pulmonary causes. This surface active material, 
or surfactant as it was called, has several important recognized 
4 
functions : it produces very low alveolar surface tension at end 
expiration, thus preventing atelectasis at low lung volumes and de¬ 
creasing the pressure necessary to inflate the lungs; it produces a 
stable balance between small and large alveoli thus preventing the 
emptying of small alveoli into larger ones, as would otherwise occur 
5 
as predicted by Laplace's law. It is now a well accepted fact that 
surfactant deficiency is the immediate etiologic factor that leads to 

2 
the development of RDS and that prematurity is the major predisposing 
factor. 
There exists controversy as to the exact composition of surfac¬ 
tant. Most investigators agree that diaplmitoyl phosphatidylcholine 
p C c 
(DPPC) ’ * is the single most important component, since it is abun¬ 
dant in lung wash material from all mammalian species tested, and its 
surface tension lowering properties are quite similar to those of 
whole lung wash. The Type II cell of the lung has been identified as 
2 c 
the site of surfactant synthesis * , and its osmiophilic inclusions, 
"lamellar" bodies, believed to be the storage site for surfactant.^ 
The lung possesses the enzymatic machinery necessary for de novo 
g 
synthesis of DPPC . Phosphatidic acid is converted to DPPC primarily 
via the CDP-choline pathway which adds choline directly to phospha¬ 
tidic acid. The alternate pathway of successive methylation of 
phosphatidyl ethanol amine to produce DPPC does not seem to be of great 
importance. The intracellular site of surfactant synthesis is not 
definitely established, although it seems evident that the finished 
product is accumulated in the lamellar bodies and then secreted into 
the alveolar spaces. 
During late gestation the fetal lung undergoes anatomical and 
biochemical changes that prepare it for the gas-exchange functions 
o 
it must assume after birth. Premature birth may mean that those 
lung masturational changes have not had time to occur. The incidence 
of RDS is extremely rare after thirty seven weeks of gestation and 
5 
increases steeply with gestational age less than thirty five weeks . 
The question naturally arises as to why a prematurely born infant does 






cause the surfactant has not been synthesized, or is the surfactant 
present inside the Type II cells but fails to be released? Most 
5 
investigators hold the first view , although there have been re¬ 
ports that Type II cells from infants that have died of RDS contain 
9 
abundant lamellar bodies . There is substantial evidence that cor¬ 
tisol enhances lung maturation and leads to increased surfactant 
synthesis^0, but there is very little known about the secretion of 
g 
surfactant and its hormonal control. 
One reason why understanding of surfactant secretion has been 
lacking is that the Type II cells comprise only a small fraction of 
the whole lung cell population, and therefore whole organ studies, 
such as the ones in the thyroid, salivary glands or the liver, are 
less revealing in the lung. Isolated Type II cells have only recent¬ 
ly been obtained^, and studies on secretion are scant. 
12 
The cell line A549 was isolated from a human lung adenocarcinoma 
and propagated in tissue culture. It is genetically homogeneous and 
should retain its properties in culture indefinitely. It incorporates 
12 13 14 
choline into DPPC * * and has been shown by electron microscopy 
to possess intracellular organelles that are strikingly similar to 
13 
lamellar bodies. Therefore it has been considered a model for the 
14 
Type II pneumocyte . Although there are legitimate objections to 
the study of differentiated cellular function in malignant cells, 
previous experience with other systems such as the steroid secreting 
15 
Y1 adrenal tumor line and the glucocorticoid sensitive hepatoma 
16 
cell line have indicated that cells can retain differentiated func¬ 
tions in the neoplastic state. It was for the above reasons, plus 




was chosen for the study of surfactant secretion. 
Since not much is known about secretion in the Type II cell the 
underlying hypothesis was that its behavior could not be very differ¬ 
ent from other secretory systems. Before concluding this introduc¬ 
tion, a few known facts about secretory processes in general will be 
outlined. 
1) The contents of secretory granules are released from 
cells (e.g. mast cells, chromaffin cells) by the mechanism 
of exocytosis, in which the secretory granule fuses with 
the cell membrane and discharges its product to the out- 
17 
side, leaving the cell membrane essentially intact. 
2) A hormone binding to its receptor on the cell surface 
usually triggers a series of intracellular events that 
leads to exocytosis^ 
3) Changes in the intracellular concentrations of calcium, 
cyclic AMP, cyclic GMP and changes in the state of the 
microfilament-microtubule system result from the hor¬ 
mone binding to the receptor, and these changes in 
1 q 20 
turn initiate the process of exocytosis * . 
4) Artificial induction of these changes can stimulate 
exocytosis bypassing the hormone-receptor interaction. 
Thus theophylline and cAMP can directly activate the 
adenyl cyclase system and calcium ionophores can in¬ 
crease the intracellular calcium ion concentration and 
. 19 
trigger exocytosis . 
5) Exocytosis results in the rapid release of stored 

5 
materials and over short time periods is independent 
19 
of active synthesis of the material to be released . 

6 
II. Objectives of the Study 
1) To verify that the A549 cells actively incorporate choline 
into disaturated phosphatidyl choline. 
2) To study the secretion of phosphatidylcholine by the 
cells into the tissue culture medium. 





e. Carbamyl Choline 
f. Calcium ionophores 
on the secretion of phosphatidylcholine. 
4) To determine the phospholipid composition of the cells 
and of the secreted material. 
5) To assess the relevance of these studies to surfactant 




III. Experimental Section 
Specific details of methodology will be presented in the Appen¬ 
dix, but a few words on the general experimental design of the secre¬ 
tion studies are presented here to enhance clarity. 
( H)-choline was used as a radioactive label for surfactant, 
since it is primarily incorporated by the cells into phosphatidycholine 
1314 32 
(PC) * . In some experiments P was used (see Appendix I for de¬ 
tails of radioactivity measurements). After a pulse of radioactive 
precursor, the release of lipid extractable radioactive product iden¬ 
tifiable as PC in a thin layer chromatography (TLC) system was measur¬ 
ed. (See Appendix II) 
Early in the study it became apparent that for a given set of cul¬ 
tures which had been grown together, and pulsed with the same amount 
of radioactive precursor, the rate of release of PC into the medium 
over consecutive one hour periods and under vasal conditions was 
strikingly uniform and reproducible. The following basic format was 
adopted in the design of the secretion studies: 
1) Each plate was a control for itself in that release of 
phospholipid over a one hour period under basal conditions 
is compared to release over the ensuing one hour periods 
in which conditions were changed. 
2) The first hour of release was called Phase I, the second. 
Phase II etc. 
3) All the medium was removed at the end of each phase and 
new medium added. If the new medium contained no serum, 
while the previous one did, the cells were washed two 

8 
times with medium without serum. 
Details will be included with each experiment and methods that apply 
to all experiments are presented in the appendices. 
A. Cell growth: 
2 
A549 cells were plated into 75 cm plastic tissue culture flasks 
6 2 
at a density of 1 x 10 cells/flask and into 55 cm plates at a den- 
5 
sity of 7 x 10 cells/plate (see Appendix III for details of culture 
techniques). At the end of three weeks of incubation there were 12 x 
r r 
10° cells/flask and 8.7 x 10 cells/plate, with medium changes approxi¬ 
mately every other day. A confluent flask contained 15 mg. of protein 
and 890 mg. of DNA. A confluent plate contained 10 mg. of protein, 
610 meg. of DNA, 0.94 uM of phospholipid phosphorus and 0.393 uM of 
phosphatidylcholine phosphorus (see Appendix III). 
B. Morphology: 
When first plated the A549 cells settle at the bottom of the 
plate or flask and within one to two hours form strong attachments to 
the plastic. Shortly thereafter they completely cover the bottom of 
the plate as a confluent monolayer, but these "early" cells are 
characterized by cytoplasm largely devoid of lamellar bodies. With 
repeated medium changes, culture maturation is characterized by an 
increasing number of cells/power field and therefore a concomitant 
reduction in cytoplasm. Numerous dark granules appear and three weeks 
after plating these granules completely fill the cytoplasm and the 
cells have achieved the smallest size they are capable of. If medium 
changes are continued, further growth is slow and characterized by the 
. ■ 
• 
- f * 
9 
formation of "mounds" of cells, i.e. loss of the monolayer configura¬ 
tion. This behavior is typical of transformed and malignant cells in 
tissue culture. The dark granules present in the cells have been prev¬ 
iously described by us as being strikingly similar to the lamellar 
13 
bodies of Type II pneumocytes . 
,3 , 
C. ( H)-choline incorporation and release from the A549 cells: 
Four equally confluent plates of A549 cells were pulsed for 
3 
twenty four hours with 10 ml of F12K-FCS containing 3 yCi/ml of ( H)- 
3 
choline. 46% of the ( H)-choline was incorporated into the cells 
during this twenty four hour period. 
The cells from two plates were collected immediately after the 
pulse, the lipid extracted and analyzed by TLC. 43.6% of the intra¬ 
cellular radioactivity was lipid extractable and 90% of this was re¬ 
covered in the PC fraction from the silica gel; the remaining counts 
were in the lysolecithin and sphingomyelin fractions. 
The other two plates were washed three times with F12K-FCS to 
remove all the unused ( H)-choline and incubated in 8 ml of non-radio¬ 
active F12K-FCS for twenty four hours, the medium was collected and 
8 ml of fresh medium added. This procedure was repeated at 24, 48, 72, 
96 and 120 hours after the end of the pulse. Lipid was extracted from 
the medium and aliquots analyzed by TLC. 
I t : 
10 
TABLE 1 
Results are the average of two plates 
Hours Total CPM in Lipid 
Extract of Medium 
Total CPM in 
PC Fraction 
24 91450 66828 
48 103320 80589 
72 92010 65721 
96 81110 62025 
120 73110 54832 
These results indicate that the A549 cells can actively incor¬ 
porate radioactively labelled choline into PC and release it into the 
medium in quantifiable amounts. 
D. Phospholipid Composition of the A549 Cells: 
The phospholipid composition of the A549 cells has been previous¬ 
ly determined by lipid extraction and fractionation by TLC^. Individ¬ 
ual phospholipids were eluted from the gel and quantitated directly 
by phosphorous assay. This method is accurate but laborious and cannot 
be applied to material secreted into the tissue culture medium since 
small quantities are secreted and the presence of phospholipids from 
the medium would contaminate the assay. A technique of isotope 
equilibration was thus used to measure the phospholipid composition of 
A549 cells. The assumption was made that after prolonged exposure of 
32 
the cells to P, the concentration of the isotope in all the intra¬ 
cellular phosphorous pools would be the same and measurement of the 
>0: • 
11 
radioactivity in each of the phospholipids should reflect the rela¬ 
tive concentration of that phosopholipid. 
A549 cells were plated and incubated as usual in F12K-FCS. One 
32 
week after plating P was added to the tissue culture medium to a con¬ 
centration of 20 yCi/ml and medium changes with this radioactive 
medium were continued every two days for two weeks. The cells were 
washed three times with Earle's Basic Salt Solution plus calcium, 
scraped off the plates, sonicated and phospholipid extracted. The 
phospholipid extract was fractionated by TLC in chloroformrmethanol: 
acetic acid:water, 50:35:4:2. The following phospholipid composition 
was obtained (average of three identically treated plates, variation 
from plate to plate was less than 2%). The phospholipid composition 
21 
obtained by phosphate determination is included for comparison. 
TABLE 2 
32 Phosphorous 
Phospholipid ( P) equilibration assay 
Lysolecithin 1.13% 2.2% 
Sphingomyelin 7.3% 6.3% 
Phosphatidylcholine 44.6% 41.3% 
Phosphatidyl serine & 
phosphatidyl inositol 11.2% 14.2% 
Phosphatidylethanol amine 22.2% 28.0% 
Phosphatidylglycerol & 
cardiolipin 10.9% 6.4% 
Equilibration of A549 cells with 
32 
P for two weeks to determine 
phospholipid composition leads to results that are quite similar to 
. f 
12 
those obtained by direct analysis of the phospholipid extract. This 
method will be subsequently applied to analysis of secreted material 
and could be of great usefulness in analyzing subcellular fractions in 
which small amounts of phospholipids are present. 
E. Effect of Serum on Phospholipid Release: 
It is known that phospholipids can exchange between serum lipo- 
22 23 24 
proteins and cell membranes both in vivo and in vitro. * * In a 
system such as this one where cellular phospholipids are radioactively 
labelled and their release into the medium measured such exchange can 
mimic net secretion. For this reason the following experiment was de¬ 
signed to study the effect of removing serum on the amount of phospho¬ 
lipid released from A549 cells in culture. 
Three equally confluent plates were pulsed with ( H)-choline for 
twenty four hours, all plates were then washed three times with 
Solution D and incubated two hours in F12K-FCS, all medium was re¬ 
moved and each plate was treated as follows: 
Plate 1 was incubated in 5 ml of F12K-FCS for one hour periods four 
times. 
Plate 3 was incubated in 5 ml F12K-FCS the first hour, in F12K the 
second and third hour and in F12K and albumin (50mg/ml) the 
fourth hour. 
Plate 2 was incubated in F12K-FCS the first hour, in F12K the second, 
third and fourth hours and in F12K-FCS the fifth hour. 
All media were collected at the end of each one hour period, the lipid 
3 
extracted and the amount of H labelled lipid recovered from the 
. 
• 




Plate Hour Period 
I II III IV V 
1 S-5355 S-5402 S-5312 S-5327 
2 S-5407 0-1630 0-813 0-502 S-4987 
3 S-5272 0-1582 0-781 A-4309 
3 
Results are CPM of ( H)-lipid recovered from the medium at the end of 
each hour period. "S," "0," "A" indicate whether serum was present (S), 
absent (0) or whether albumin was added (A). These results are also 
plotted in fig. 1. 
It is clear that a marked reduction in the level of ( H)-labelled 
phospholipid recovered from the medium occurs upon removal of the serum, 
and that this effect can be reversed by the re-addition of serum or 
high albumin concentration to the medium. From this point on the 
serum mediated release will be called phospholipid exchange and any 
non-serum mediated release will be termed secretion. 
F. Effect of Theophylline, Cyclic AMP, Carbamyl Choline and Isopro¬ 
terenol on Phospholipid Secretion: 
The possibility of increasing surfactant secretion in the A549 
cells by stimulating the adenyl cyclase system, or by stimulating 
adrenergic and cholinergic receptors was studied. 
■» 
' . .  
14 
3 
Nine confluent plates were pulsed with ( H)-choline, the cells 
were washed three times with Solution D at the end of the pulse and 
incubated two hours in F12K-FCS. This medium was removed and discard¬ 
ed and all the plates incubated for one hour in F12K-FCS (Phase I). 
Each plate was incubated a second hour (Phase II) in F12K-FCS with 




3H CPM in lipid extract of medium collected at the end of 
Plate I ADDITION II 
1 2353 none 2521 
2 2319 10 3M Theophylline 2483 
3 2411 ll 2302 
4 2513 lo"3M cAMP 2602 
5 2427 II 2493 
6 2428 
-4 
10 M Isoproterenol 2648 
7 2501 ll 2572 
8 2462 
-4 
10 M Carbamyl Choline 2511 
9 2362 II 2417 
Under these conditions, theophylline, cAMP, isoproternol and 




Figure 1: Effect of Serum on Phospholipid Release 
HOUR 
3 
Each point represents CPM of H labelled phospho¬ 
lipid released into the medium during each one hour 
incubation. Sequences 1, 2 and 3 represent plates 
1, 2 and 3 respectively. Plate 1 was incubated in 
10% serum through four straight one hour periods. 
Plate 2 was incubated in serum the first hour, with¬ 
out serum the 2nd, 3rd and 4th hours and again in 
serum the fifth hour. Plate 3 was incubated in 
serum the first hour, without serum the second and 
third hours, and in albumin (50 mg/ml) the fourth 
hour. See Table 3 for further details. 
■ ( ■' 
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16 
G. Studies with Calcium Ionophores A23187 and X537A: 
Calcium ionophores are lipid soluble substances of microbiologi¬ 
cal origin that have the ability to bind calcium at relatively high 
concentrations, diffuse across lipid barriers such as cell membranes 
and release the calcium if the intracellular concentration of the ion 
19 25 
is sufficiently low * . Since most cells that synthesize and 
store a product for secretion need a rapid influx of calcium for 
19 
exocytosis to take place , the calcium ionophores provide an inval¬ 
uable tool for determining if a given cell population is capable of 
secreting the substance in question following a calcium stimulus. 
Increasing the extracellular calcium concentration will not usually 
initiate exocytosis since the cell membrane is relatively impermeable 
to calcium and an active calcium pump at the membrane maintains a 
concentration gradient with the intracellular concentration being 
19 
several orders of magnitude lower than the extracellular . The 
effect of two calcium ionophores, A23187 and X537A were thus studied. 
(See Appendix IV for details of ionophore preparation). 
1. Effect of ionophores on secretion (medium containing serum) 
3 
Five plates were pulsed with ( H)-choline for twenty four hours 
in F12K-FCS, the medium was removed and discarded and the plates 
incubated two hours in F12K-FCS, this medium was again discarded 
and the cells incubated for two consecutive one hour periods in 
F12K-FCS with the ionophores being added in the second hour. 






Results expressed at ( H) CPM in PC released into the medium during 







(first hour) ADDITIONS II (second hour) 
10108 none 9991 
10821 A23187 (10 mcg/ml) 26927 
9973 II 29216 
9950 X537A (20 mcg/ml) 16915 
10057 II 17096 
2. Effect of ionophores in the absence of serum: 
Three plates were pulsed as above and incubated for two hours 
in F12K-FCS. Each plate was then washed three times with F12K and 
incubated for two consecutive one hour periods in F12K (5 ml) with 
ionophore addition being made during the second hour period. All 
media were collected at the end of each hour and analyzed. 
TABLE 6 
PLATE I(first hour) ADDITIONS II(second hour) 
1 1410 none 1091 
2 1427 A23187 (lOmcg/ml) 15213 
3 1381 II 15021 
3 .... . _ 3 
results are H CPM in PC released into the medium during each hour. 




Six plates were pulsed with ( H)-choline as above and incubated 
for two hours in F12K-FCS, each plate was then incubated for two con¬ 
secutive one hour periods with ionophores and EDTA being added in the 
second hour. All media were collected at the end of each hour and 
analyzed. 
TABLE 7 
Results expressed as JH CPM in 
each hour period 
PC released into the medium during 
PLATE I(first hour) ADDITIONS II(second hour) 
1 10802 none 11152 
2 10770 A23187(10mcg/ml) 27020 
3 10007 " & EDTA (2.5mM) 11705 
4 10384 X537A(20mcg/ml) 19864 
5 10608 " & EDTA (2.5mM) 17904 
6 10556 EDTA (2.5 mM) 10375 
These results are plotted in figure 2. 
4. Dose response curve to A23187: 
Other investigators have reported that magnesium can inhibit 
19 
the effect of the ionophore A23187 . I tested this hypothesis on 
our system, and indeed, found that higher responses could be obtained 
if the medium did not contain magnesium. For this reason the follow¬ 
ing experiment was carried out in Earle's Basic Salt Solution with 
ImM calcium but no magnesium, serum was also omitted to minimize phos¬ 
pholipid exchange and optimize conditions for secretion. 
. 
19 
Figure 2: Effect of EDTA on Response to Ionophores 
HOUR 
3 
Each point represents CPM of H labelled phospha¬ 
tidylcholine released during each hour of incuba¬ 
tion. During the first hour (I) all the plates 
were incubated under basal conditions and during 
the second hour (II) ionophores and EDTA were added. 
Lines 1-5 represent plates 1-5. During the second 
hour (II) plate 1 received no additions, plate 2 
received A23187, plate 3 received A23187 plus EDTA, 
plate 4 received X537A, plate 5 received X537A 





Seven confluent cultures were pulsed with 30 yCi of ( H)-choline 
in 10 ml of F12K-FCS for twenty four hours, each plate was then incu¬ 
bated for two hours in 10 ml of EBSS with calcium and 10% fetal calf 
serum, washed three times with EBSS-Ca and incubated for two consecu¬ 
tive one hour periods in 5 ml of EBSS-Ca, different concentrations of 
ionophore were added in the second hour. All media were collected at 
the end of each one hour period and the phosphatidylcholine measured. 
TABLE 8 
PLATE I(first hour) ADDITIONS 
(A23187 mcg/ml) 
II(second hour) 
1 1697 0 637 
2 1513 0.1 1452 
3 1602 0.3 2307 
4 1713 1.0 3405 
5 1681 3.0 8715 
6 1653 10.0 34697 
7 1612 30.0 99097 
3 
Results are CPM of H in phosphatidylcholine extracted from the 
medium at the end of each one hour incubation. 
These results are plotted in figure 3. 
Observation of the cells under the microscope within minutes 
after the addition of A23187 (3 and 1- mcg/ml) revealed a marked 
diminution in the number of intracellular granules. 
These experiments show that both X537A and A23187 cause a marked 





presence and the absence of serum. Forty five percent of the released 
PC was disaturated (DPPC). (See Appendix II for details of lipid analy¬ 
sis). 
The experiments with EDTA show that chelation of calcium abolish¬ 
es the response to A23187 but not to X537A. The experiments with EDTA 











Figure 3: Dose Response Curve to A23187 
J I I I I l 
O.l 0.3 1.0 3 0 10 30 
A 2 318 7 (mcg/ml) 
3 
Each point represents CPM of H labelled phosphatidylcholine 
released into the medium after stimulation of each of six 
plates with A23187 at different concentrations minus the 





5. Effect of A23187 on release of intracellular contents: 
To determine if the increase in phospholipid release caused by 
A23187 was due to damage to the cells and a non-specific release of 
intracellular contents, four confluent plates were incubated for one 
hour (Phase I) in EBSS with calcium, and then one hour (Phase II) in 
EBSS with calcium and A23187 (10 mcg/ml). All the media were collected 
at the end of each hour and the activity of Lactic Dehydrogenase re¬ 
leased into the medium assayed. 
TABLE 9 
Results expressed as LDH International Units released into the medium 
during each hour period. Results are average of four plates. 
Phase I Phase II 
18 18 
Lysing the cells by incubating them in hypotonic solution caused the 
release of over 1000 LDH units. 
As an additional control the release of free amino acids into 
the medium was also determined and these results also indicated no 
significant loss of intracellular contents following stimulation 
with A23187. 
6. Phospholipid composition of secreted material: 
The percent composition of the different phospholipid classes 
was determined for the secreted material by a method similar to the 
one described for the phospholipid composition of the whole cells. 
Four plates were allowed to reach confluence by incubating them for 
32 
three weeks in F12K-FCS containing 20 yCi/ml of P. Medium changes 

24 
were done every two days. At the end of three weeks each plate was 
washed three times with F12K and then incubated two hours in F12K-FCS 
without the radioactive precursor. Each plate was then washed three 
times with EBSS-Ca and incubated for one hour in 5 ml of EBSS-Ca 
(Phase I). The media were collected and 5 ml of EBSS-Ca containing 
A23187 (5 mcg/ml) were added to each plate. All media were collected 
at the end of each hour, the lipid was extracted and analyzed by TLC. 




Results are expressed as P CPM in each phospholipid class released 
into the medium. Percentages were calculated by dividing the CPM for 
each phospholipid by the total CPM in phospholipid released during each 
hour. 
Phospholipid Phase I 
CPM 
% Phase II 
CPM 
% 
Lysolecithin 260 3.6% 2883 3.4% 
Sphingomyelin 673 9.2% 13010 15.5% 
Phosphatidylcholine 2601 35.4% 35654 42.4% 
Phosphatidylserine & 
phosphatidylinositol 665 9.1% 8121 9.7% 
Phosphatidylethanol amine 1910 26.6% 15645 18.6% 
Phosphatidyl glycerol & 
cardiolipin 742 10.1% 3348 3.9% 
Each result is the average of four plates. The phosphatidyl choline 
fraction from the Phase II material (stimulated secretion) was further 





The results show that A23187 causes a marked increase in the 
secretion of all phospholipid classes, with a selective enrichment in 
the sphingomyelin and phosphatidylcholine fractions, and a relative 




The above experiments were designed to evaluate the A549 cell 
line as a model for surfactant secretion by the Type II pneumocyte. 
13 
We have previously shown that the A549 cells, when fully confluent, 
are rich in lamellar bodies, the morphologic hallmark of the Type II 
cell. We also showed that sixteen percent of the phosphatidycholine 
in the cells is disaturated (DPPC), but this figure is thirty nine per¬ 
cent when the lamellar bodies are isolated and analyzed. The phos¬ 
phatidylcholine secreted by the cells into the tissue culture medium 
is forty six percent disaturated. For comparison. Type II cells 
isolated from rabbits have fifty point five percent disaturated PC, 
21 
and PC from human lung lavage is fifty four percent disaturated . 
The figures for whole cell disaturated PC are relatively low, but a 
marked enrichment is seen when the lamellar bodies and the secreted 
material are analyzed. The similarity between the disaturated PC 
in lamellar bodies and secreted material in the A549 cells suggests 
that the secreted material is coming from the lamellar bodies. The 
3 
cells actively incorporate H-choline into PC and DPPC. This combined 
with their rapid growth in tissue culture and the above mentioned 
similarities with the Type II cell made them an attractive system in 
which to look at surfactant secretion. 
Before looking at ways to stimulate secretion, it was necessary 
to determine if phospholipid exchange between the cells and the serum 
was occurring. We showed that changing from ten percent fetal calf 
serum to no serum caused a rapid and marked decrease in the amount of 
3 
H labelled lipid recovered from the medium; this effect could be 
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rapidly reversed by the readdition of serum or a high concentration 
of albumin to the medium. 
14 
It had been previously reported that carbamyl choline and 
isoproterenol stimulate phospholipid secretion in the A549 cells, I 
tested these agents on the cells and obtained no response. To test 
tf stimulation of the adenyl cyclase system could increase secretion, 
cAMP and theophylline were tested, and no response was obtained. 
Calcium is known to stimulate exocytosis by secretory cells, 
and a calcium influx hypothesis of stimulus secretion coupling has 
g 
been proposed . Calcium ionophores are natural antibiotics that pro¬ 
duce an influx of calcium into cells, and have been shown to stimu- 
19 
late exocytosis in multiple systems . The ionophores A23187 and 
X537A, were tested and were found to markedly stimulate PC secretion 
both in the presence and in the absence of serum, indicating that 
phospholipid exchange was not involved. The effect of A23187 could 
be blocked by EDTA and was actually enhanced by removing magnesium 
from the medium, indicating that it was calcium mediated. EDTA 
alone produced no change in the serum dependent release, again 
separating phospholipid exchange from calcium induced secretion. The 
effect of X537A was not blocked by EDTA. The reason for this dis¬ 
crepancy can be explained from the fact that A23187 can only bind 
divalent cations while X537A can also bind sodium and potassium. 
Since the ionophores can only enter the cell when complexed with an 
ion, in the presence of EDTA A23187 cannot enter the cell while X537A 
can still enter complexed with sodium or potassium. Once inside the 
cell X537A can liberate calcium from mitochondria, which are known 
19 
to be rich in calcium. 
■ 
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The response to A23187 was dose dependent and the range of 
19 
responsiveness is similar to that reported in other systems 
Following stimulation with ionophores a marked diminution in the 
number of intracellular granules could be observed. 
That the release of phospholipids was not due to leakage of 
intracellular contents from cellular damage was indicated by the 
lack of release of free amino acids and of the intracellular enzyme 




The A549 cell line had been considered a model for the Type 
II cell. Two new properties of this cell line have been discovered 
and described here: 1) A phospholipid exchange process between cellu¬ 
lar and serum phospholipids has been demonstrated. 2) Calcium 
dependent exocytosis is one mechanism by which disaturated phospha¬ 
tidylcholine is released from cells. Extrapolation of these results 
to Type II cells in vivo remains to be shown. Nevertheless, these 
findings are very relevant to current experimental study of the pul¬ 
monary surfactant system. Subsequent investigation of physiologic 








Radioactive Labelling and Liquid Scintillation Counting 
Cells were plated at a density of 10 cells/plate and brought 
to confluence with medium changes (complete medium), every other day 
for three to four weeks. They were then pulsed with 30 uCi of ( H)- 
choline (methyl H, 4.3 Ci/mmol.), in 10 ml. of F12K-FCS for twenty 
four hours. Each plate was then washed three times with 10 ml of 
Solution D to remove as much as possible of extracellular radioactive 
material. Each plate was incubated for two hours in 10 ml. of F12K-FCS 
and then washed once before beginning any secretion studies. 
32 Labelling with P is described in the appropriate experimental 
sections. 
Counts per minute on radioactive samples were determined by 
liquid scintillation counting (LSC), in vials containing 0.5 ml. of 
water and 14.5 ml. aquasol (NFN). Counting was performed in a Beckman 
3 
LS 100C Liquid Scintillation Counter. Efficiency of H counting was 
determined with known reference standards. 
3 
( H)-choline labelled phospholipids were counted by placing 
lipid extract in ChCl^ in an LSC vial, drying under N^, adding 0.5 mis. 
of H^O and 11.5 ml. aquasol, vortexing and then counting. Specific 
3 
H choline labelled phospholipid from TLC silica gels were counted 
by placing the scraped spot from the TLC plate in an LSC vial, add¬ 
ing 0.5 ml. H20 and 11.5 ml. aquasol, vortexing the vial vigorously 
and allowing them to sit for twenty-four hours to allow for maximal 






P labelled phospholipid from either lipid extracts or silica 
3 3 
gels were counted by the same procedure as for H-choline. H-choline 
32 
and P were counted in appropriate channels. A blank was always in¬ 
cluded with each set of samples and the background CPM were substract- 
ed from all results. 
The efficiencies of counting were determined with known reference 
standards and were as follows: 
Isotope Medium Scintillation Mixture Efficiency % 
lipid residue 
on silica gel 
lipid residue 













A. Collection of Medium Samples for Analysis: 
Culture medium for analysis was removed from plates by pipetting. 
If the medium did not contain serum, enough FCS serum was added after 
collection to make it 10% FCS, this 10% dilution factor was always 
corrected for in any measurements made on such samples. 
Each medium sample was then centrifuged at lOOOg's for ten 
minutes and the supernatant saved for analysis. 
27 
B. Lipid Extraction (procedure of Bligh and Dyer): 
Lipids from sonicated cell suspensions or from tissue culture 
media in secretion studies were extracted in glass tubes by adding 
chloroform and methanol with a final ratio of chloroform:methanol: 
water of 1:2:0:8. This mixture was vigorougly vortexed for two 
minutes and a monophasic system obtained. The monophasic system was 
then centrifuged at 20Q0g's for twenty minutes and the pellet ob¬ 
tained is discarded, it contained insignificant amounts of lipid. 
Chloroform is then added to the monophasic mixture to a ratio of 
2:2:0.8, chloroform:methanol:water, and the tube is vigorously vot- 
texed for thirty seconds. Water is then added to a final ratio of 
2:2:1.8, and the tube again vortexed for thirty seconds. After cen¬ 
trifuging for twenty minutes at lOOOg's a sharply separated two phase 
system is obtained with practically 100% chloroform-lipid at the 
bottom and methanol-water at the top. The chloroform layer is then 




-20°C until ready for analysis. 
2i 28 
C. Thin Layer Chromatography: * 
Radioactive lipid extracts were analyzed by thin layer chromato¬ 
graphy on Kontes/Quantum Pre-adsorbent Silica Gel TLC plates, (20 x 20 
cm., 19 channels, 250 u thickness). 
Solvent systems used for development were: chloroform:methanol: 
10.5N NH^OH, 60:35:8; chloroform:methanol:acetic acid:water, 50:35:4:2. 
Individual samples were spotted on each channel in small volumes 
(25-50 mcl.) of chloroform and the plates were then allowed to run 
until the solvent front reached the top. The plate was then removed 
from the developing tank, allowed to dry, and the spots were visualized 
in a tank saturated with iodine vapor. Individual spots were scraped 
off with a surgical blade and transferred to liquid scintillation vials 
for counting. Known phospholipid standards were run with and alongside 
the samples to obtain better visualization in the iodine tank. 
D. The percent disaturated phosphatidylcholine was determined by the 
29 




Tissue Culture Methods 
A. Culture Techniques: 
The A549 cell line is maintained as a monolayer culture in 
2 
75 cm. plastic tissue culture flasks in 14 ml. F12K medium with 10% 
heat inactivated fetal calf serum, and containing 100 units/ml. Peni¬ 
cillin G, 100 mcg/ml. Streptomycin and 0.25 mcg/ml. Fungizone. The 
cells were incubated at 37°C under 95% air and 5% CO^ in a humidified 
incubator. 
B. Definition of Tissue Culture Media Used: 
F12K - F12K medium (Gibco) 
FCS - Fetal calf serum, heat inactivated (Gibco) 
F12K-FCS -F12K 90% and FCS 10% 
EBSS - Earles Basic Salt Solution, a phosphate and bicarbonate 
buffered saline solution, pH 7.4, without calcium or 
magnesium. When calcium was added (ImM) it will be indicated 
as EBSS-Ca. 
Solution D - Puck's Solution D, a phosphate buffered saline, pH 7.4 
Complete medium-F12K-90%, FCS-10%, Penicillin G-100 U/ml., 
Streptomycin-100 meg./ml., Fungizone-0.25 meg./ml. 
C. Subculturing Technique: 
2 
Subculturing was performed by treating a confluent 75 cm. flask 
with 5 ml. of 0.2% trypsin in phosphate buffered saline at a pH of 
' 
36 
7.4 for 10-20 minutes at room temperature. The flask was shaken for 
10-20 seconds every two minutes until the cell monolayer came off in 
sheets. The sheets were then broken up by pipetting up and down with 
a 10 ml. pipette until a fine cell suspension was obtained (single 
2 
cells or clumps of 2-4 cells each). The contents of a 75 cm. are 
2 
split 1:10 if transferred to 75 cm. flasks and 1:14, if transferred 
2 
to 55 cm. plates. A medium change was always done twenty-four hours 
after subculturing and every two to three days thereafter. 
Cell numbers were determined by counting at least 400 cells 
with a hemocytometer, and viability was determined by trypan blue dye 
, . 30 
exclusion . 
Morphologic observations were made by phase contrast microscopy. 
D. Collection of Cells: 
Cells for DNA, proteins, or lipid studies were obtained by 
scraping with a rubber policeman in phosphate buffered saline, pH 
7.4, at 4°C. The cell suspension was then sonicated at a setting of 
30 Watts for 10 seconds at 4°C. The cells were sonicated three times 
with one minute intervals in between sonication to maintain a low 
temperature. 
E. Protein and DNA Determinations: 
Protein content of sonicated cell suspension was determined by 
31 
the method of Lowry , with BSA used as a standard. DNA content was 
determined by a modification of the method of Burton with Calf Thymus 
32 
DNA as a standard . 

37 
F. Phosphate Determination: 
Phosphate determinations on whole cell lipid and phosphatidyl - 
33 




Preparation of Ionophores A23187 and X537A: 
X537A was dissolved in pure ethanol at a concentration of 2 mg/ml 
and added directly to the plates in experiments. A23187 was prepared 
by mixing 10 mg. of A23187 and 100 mg. of PVP (Polyvinyl Pyrrolidone) 
in a small volume of chloroform, the mixture was dried under vacuum 
and redissolved in 2 ml. of pure ethanol. On the day of an experiment 
the ethanol solution was diluted 1:10 with distilled water and approp¬ 
riate volumes added directly to the plates. 
Both X537A and A23187 exist as microsuspensions in aqueous media, 
and filtering of such solutions through micropore filters leads to 
loss of ionophore activity. 
Appropriate controls with PVP and ethanol were run in several 






The A549 cells were provided by Dr. A. Gadzar of the National 
Cancer Institute, the cells had been previously grown in RPMI medium, 
but were successfully adopted to F12K-FCS upon receipt in our labora¬ 
tory. The cells were received at passage 20 and all the studies re¬ 
ported here were performed on cells with passage numbers 28-35. 
Tissue culture media, serum, and antibiotics were purchased from Grand 
Island Biologicals Company (GIBCO), the fetal calf serum was heat 
inactivated and was all from the same lot. Tissue culture flasks 
were purchased from Corning and plates from Falcon. 
Chloroform and methanol, reagent grade, were purchased from 
Mai 1inckrodt; Ammonium hydroxide and acetic acid (glacial) were pur¬ 
chased from Baker. Thin layer chromatography plates were purchased 
from Kontes/Zuantum, phospholipid standards were purchased from 
Analabs. 
A23187 was a gift of Eli Lilly and Co. and X537A was a gift 
from Hoffman LaRoche. Carbamyl Choline, isoproterenol, theophylline, 
dibutiryl cyclic AMP, bovine albumin and EDTA were purchased from 
Sigma. Polyvinylpyreolidone (MW 40,000,pharmaceutical grade) was 
purchased from GIBCO. Radiochemicals and aquasol were purchased 
from New England Nuclear. Liquid scintillation counting was per¬ 
formed on a Beckman LS100C. Sonication of cells was performed on a 
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